These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 3048495

  • 1. In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
    Kedar E, Tsuberi BZ, Landesberg A, Anafi M, Leshem B, Gillis S, Urdal DL, Slavin S.
    Bone Marrow Transplant; 1988 Jul; 3(4):297-314. PubMed ID: 3048495
    [Abstract] [Full Text] [Related]

  • 2. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S, Mumcuoglu M, Landesberg-Weisz A, Kedar E.
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens.
    Leshem B, Tsuberi BZ, Lebendiker Z, Anafi-Ayalon M, Shalit M, Weiss L, Slavin S, Kedar E.
    Transplantation; 1987 Jun; 43(6):814-7. PubMed ID: 2954282
    [Abstract] [Full Text] [Related]

  • 4. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M, Naparstek E, Slavin S.
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [Abstract] [Full Text] [Related]

  • 5. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
    Pruijt JF, Lindley IJ, Heemskerk DP, Willemze R, Fibbe WE.
    Stem Cells; 1997 Mar; 15(1):50-5. PubMed ID: 9007222
    [Abstract] [Full Text] [Related]

  • 6. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
    Hu Y, Ma L, Ma GJ, Jiang XY, Zhao CH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
    [Abstract] [Full Text] [Related]

  • 7. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
    Naparstek E, Ohana M, Greenberger JS, Slavin S.
    Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
    [Abstract] [Full Text] [Related]

  • 8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 9. Accelerated recovery of peripheral blood cell counts in mice transplanted with in vitro cytokine-expanded hematopoietic progenitors.
    Muench MO, Moore MA.
    Exp Hematol; 1992 Jun; 20(5):611-8. PubMed ID: 1587307
    [Abstract] [Full Text] [Related]

  • 10. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF, Goldwasser E, Fitch FW.
    J Immunol; 1988 Oct 15; 141(8):2635-42. PubMed ID: 2971726
    [Abstract] [Full Text] [Related]

  • 11. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K, Vos B, Kang-Er Z, Guiffre A, Seymour R, Gillis S.
    Cytokines Mol Ther; 1995 Mar 15; 1(1):47-55. PubMed ID: 9384663
    [Abstract] [Full Text] [Related]

  • 12. Cytokines transduced bone marrow stromal cell lines promote immunohematopoietic reconstitution in mice after allogeneic bone marrow transplantation.
    Li A, Jiang J, Zhang Q, Hao J, Xie S.
    Immunol Lett; 2005 May 15; 98(2):216-24. PubMed ID: 15860221
    [Abstract] [Full Text] [Related]

  • 13. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L, Zijlmans JM, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE.
    Exp Hematol; 1996 Oct 15; 24(12):1387-93. PubMed ID: 8913284
    [Abstract] [Full Text] [Related]

  • 14. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 15. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Dec 15; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 16. Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
    Wu DD, Nayar R, Keating A.
    Exp Hematol; 1994 Jun 15; 22(6):495-500. PubMed ID: 7514543
    [Abstract] [Full Text] [Related]

  • 17. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J, Wang MG, Pearson DA, Szot GL, Sykes M.
    Transplantation; 1994 Dec 27; 58(12):1385-93. PubMed ID: 7809932
    [Abstract] [Full Text] [Related]

  • 18. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S.
    J Immunol; 1994 Sep 15; 153(6):2562-7. PubMed ID: 8077666
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation.
    Naldini A, Fleischmann WR, Ballas ZK, Klimpel KD, Klimpel GR.
    J Immunol; 1987 Sep 15; 139(6):1880-4. PubMed ID: 2442258
    [Abstract] [Full Text] [Related]

  • 20. Induction of graft-versus-leukemia (GVL) activity in murine leukemia models after IL-2 pretreatment of syngeneic and allogeneic bone marrow grafts.
    Zeis M, Uharek L, Glass B, Gaska T, Gassmann W, Mueller-Ruchholtz W.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):711-5. PubMed ID: 7889004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.